{
    "2018-05-28": [
        [
            {
                "time": "",
                "original_text": "【互通资金动向】北上资金连续三个月增持医药生物 爱尔眼科通化东宝成“新宠”",
                "features": {
                    "keywords": [
                        "北上资金",
                        "医药生物",
                        "爱尔眼科",
                        "通化东宝"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "药品注册审评审批优化 利好创新药公司",
                "features": {
                    "keywords": [
                        "药品注册",
                        "审评审批",
                        "创新药"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "[强于大市评级]医药行业周报：看好医药板块 持续推荐疫苗板块及蓝帆医疗",
                "features": {
                    "keywords": [
                        "医药行业",
                        "疫苗",
                        "蓝帆医疗",
                        "强于大市评级"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "疫苗"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "[增持评级]医药生物行业周报：“互联网+医疗健康”发展意见正式落地 关注工业端数据回落",
                "features": {
                    "keywords": [
                        "医药生物",
                        "互联网+医疗健康",
                        "工业端数据",
                        "增持评级"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药生物",
                        "互联网+医疗健康"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "本周股市三大猜想及应对策略：股指持续震荡筑底？",
                "features": {
                    "keywords": [
                        "股市",
                        "股指",
                        "震荡筑底"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}